Oral poisoning: an update

Size: px
Start display at page:

Download "Oral poisoning: an update"

Transcription

1 : an update Catherine Ward MBBS BSc Hons FRCA Mark Sair PhD MRCP FRCA Key points The mainstay treatment of poisoning is resuscitation and supportive care. Poisoning should be considered in any patient exhibiting bizarre behaviour, a reduced conscious level, or unexplained physiological instability. Ipecac is no longer recommended in the treatment of acute poisoning. Activated charcoal should be given within 60 min of ingestion of poison but may have an effect for up to 2 h or longer post-ingestion. Acetaminophen levels are mandatory in all cases of adult overdose. Catherine Ward MBBS BSc Hons FRCA Specialist Registrar Derriford Hospital Plymouth The Anaesthetic Department Level 5, Torbay District General Hospital Lawes Bridge Torquay TQ2 7AA Tel: þ Fax: þ caf.ward@btinternet.com (for correspondence) Mark Sair PhD MRCP FRCA Consultant in Intensive Care Medicine and Anaesthesia Derriford Hospital Plymouth Department of Anaesthesia Level 9 Plymouth Hospitals NHS Trust Plymouth Devon PL6 8DH 6 Oral poisoning: an update Acute poisoning accounts for hospital admissions per year in the with in excess of 4000 deaths reported in England and Wales per annum. Although the majority of poison-related deaths occur in the community, reduction of in-hospital morbidity and mortality remains an important challenge. The largest proportion of enquiries to the National Poisons Information Service (NPIS) and Guy s and St Thomas Poisons Unit (GTPU) are concerning pre-school children. 1 A recent report indicated that 85% of poisonings occur in the home. Drugs accounted for the majority, but industrial chemicals and household products were involved in a significant number. Only one-third of cases were deliberate. The medications most commonly taken were acetaminophen, non-steroidal analgesics, and antidepressants. 2 The NPIS was commissioned by the Health Protection Agency and consists of five regional centres that operate a 24 h information service to health-care staff on the diagnosis, treatment, and management of poisoning. GTPU ceased to be a provider to NPIS in November 2005 and operates independently with support from Guy s and St Thomas Foundation Trust. Toxbase, the online toxicology database, was established in 1998 and NPIS recommends it as the first point of contact for registered health-care professionals. The website provides easily accessible information on acute poisoning and its management. 3 Initial approach to the poisoned patient Poisoning should be considered in any patient exhibiting bizarre behaviour, a reduced conscious level, or unexplained metabolic, cardiovascular, or respiratory instability. All cases are managed as acute medical emergencies using an ABC approach regardless of the agent used. Rare exceptions include patients poisoned with organophosphates, where health-care workers first need to protect themselves from the agent, and cyanide poisoning, where the antidote for cyanide is immediately required. All cases require: resuscitation; risk assessment; substance identification; specific treatment (if available); a period of observation. A focused and detailed poisoning history and examination are required to identify specific physical signs of poisoning followed by the selective use of antidotes and laboratory tests (Table 1). Most poisoned patients require supportive treatment only. A risk assessment should be performed by obtaining specific information from ambulance personnel or witnesses regarding the nature, timing, and amount of drug or poison. One-third of cases involve more than one toxin and alcohol is a common contributing factor. The patient s clothing should be checked for notes or blister packets, which may give a clue to quantity and type of drug ingested. In cases of deliberate self-harm, there may be previous hospital admissions to aid diagnosis. The patient s general practitioner should be contacted for previous history as family or witness sources are often unreliable. Supportive care and monitoring Patients suspected of being exposed to a poison or drug should be monitored in an appropriate clinical environment. Where coma is inevitable, patients should be intubated pre-emptively or at the first sign of deterioration in level of consciousness. Tracheal intubation will protect the airway and allow early administration of activated charcoal (AC) via a nasogastric tube if required. Patients who are at risk of cardiac instability and acidosis should have continuous ECG and invasive arterial pressure monitoring with regular blood gas analysis. Body temperature and serum glucose should be checked and i.v. dextrose administered if required. doi: /bjaceaccp/mkp039 Advance Access publication 15 December, 2009 Continuing Education in Anaesthesia, Critical Care & Pain Volume 10 Number & The Author [2009]. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please journals.permissions@oxfordjournal.org

2 Table 1 Specific signs in poisoning and overdose Toxidrome Drug Common Findings Other signs and symptoms Potential Treatments Anticholinergic Scopolamine, atropine Altered mental status, dilated pupils, urinary retention, hyperthermia, dry mucous membranes Cholinergic Investigations Acetaminophen levels are considered mandatory in all cases of adult overdose and should be taken 4 h post-exposure. Salicylate levels are not recommended in the asymptomatic patient. Screening for substances of abuse can be achieved quickly with readily available commercial urine kits. Other laboratory tests include full blood count, urea and electrolytes, lactate, liver function tests, and coagulation studies. Where poisoning is caused by specific agents, for example, methanol or carbamazepine plasma levels are taken 4 hourly to allow refinement of risk assessment and to gauge the response to enhanced elimination techniques. A chest radiograph may indicate pulmonary oedema, which is suggestive of poisoning with narcotics or salicylates. Abdominal radiographs can identify packets of drugs smuggled in body packers. Radiological investigations are otherwise rarely required in the setting of acute poisoning. Gastric decontamination There is much debate regarding the use of the so-called decontamination triangle of forced emesis, gastric lavage, and single-dose AC. Decontamination strategies are not without side-effects and the risk:benefit ratio should be considered before administration. The American Academy of Clinical Toxicology and European Association of Poisons Centres state that gastrointestinal decontamination should not be administered routinely. Induced emesis Organophosphates; carbamates Salivation, lacrimation, sweating, nausea, vomiting, urination, defaecation, muscle weakness, bronchorrhoea Ipecac induces vomiting by both direct gastrointestinal effects and central nervous system actions. It is administered at a dose of 30 ml in adults followed by water 240 ml. Emesis typically occurs within 20 min and persists for min. Several studies have compared ipecac with single-dose AC. Ipecac conveys no benefit, whether given alone or combined with AC. 4 Side-effects include Seizures, dysrrhythmias, rhabdomyolysis Bradycardia, dilated or constricted pupils, seizures, respiratory failure, paralysis Opioid Heroin, morphine CNS and respiratory depression, small pupils Hypothermia, bradycardia, respiratory arrest, acute lung injury Salicylates Aspirin Altered mental status, respiratory alkalosis, Low-grade fever, ketonuria, acute lung metabolic acidosis, tinnitus, hyperpnoea, injury tachycardia, sweating Serotonin Meperidine; MAOI, Altered mental status, increased muscle tone, Intermittent whole body tremor Syndrome SSRI, TCA hyperreflexia, hyperthermia Sympathomimetic Cocaine; amphetamine Agitation, dilated pupils, excessive sweating, tachycardia, hypertension, hyperthermia Seizures, rhabdomyolysis, myocardial infarction, cardiac arrest, hyperthermia prolonged time in the Accident and Emergency Department and increased incidence of aspiration pneumonitis. Its use is no longer recommended. 5 Gastric lavage Gastric lavage is performed by placing a large-bore orogastric tube (30 40 F), instilling and re-aspirating several litres of water to wash out the stomach contents. This is continued until no more pill fragments are identified in gastric contents. 6 Patients must be able to protect their own airway. Drug absorption is not reduced if lavage is commenced 1 h or more after drug ingestion. Paradoxically, one study suggested that gastric lavage promotes post-pyloric transfer of poison into the small intestine where it is more rapidly absorbed. There are no data demonstrating improved clinical outcome with gastric lavage and its use is associated with significant morbidity and mortality. Complications include gastrointestinal tract perforation and aspiration. Activated charcoal Physostigmine; sedation with benzodiazepines, cooling, supportive management Airway protection and IPPV, atropine, pralidoxime Airway protection, IPPV naloxone Multi-dose AC, alkalinization of urine, K þ repletion, haemodialysis, hydration Cooling, benzodiazepines Cooling, sedation with benzodiazepines, hydration Most drugs and chemicals are absorbed by AC. It creates weak van der Waals forces that bind with the substance in the gastrointestinal tract. The numerous charcoal particles provide a large enough surface area to prevent further absorption. AC should be administered orally or nasogastrically via a 16 F tube in the intubated patient. The charcoal to toxin ratio is 10:1 with a usual dose of g or 1 g kg 21 in a child. This dose should be given within 1 h of poison ingestion. 7 Its efficacy is time-dependent, with nearly 90% reduction in absorption 30 min after drug ingestion decreasing to 30% at 1 h. 8 It has been shown to reduce acetaminophen absorption up to 2 h after ingestion. AC is unpalatable and can cause vomiting, thus in children it can be mixed with ice cream. Patients should also be warned that it will make their stools black. It is not recommended in poisoning with lithium, iron, alcohol, methanol, ethylene glycol, petroleum distillates, Continuing Education in Anaesthesia, Critical Care & Pain j Volume 10 Number

3 corrosives, acids, or alkalis. Repeated doses of 25 g per 4 6 hourly can be of benefit for poisoning with slow release formulations, for example, salicylate, barbiturates, theophylline, quinine, digoxin, carbamazepine, phenytoin, and dapsone. Multiple doses interrupt the enterohepatic circulation of the drug, reducing the plasma levels, and there are data that this reduces the duration of toxicity. A major but rare adverse effect from repeat doses is acute bowel obstruction from charcoal concretions, which is particularly likely in the presence of an anticholinergic ileus. Whole bowel irrigation Whole bowel irrigation (WBI) aims to reduce the time for ingested substances to be absorbed. It requires the administration of polyethylene glycol (PEG) litres solution per hour and is best administered through a 12 F feeding tube. The head of the bed should be elevated to 45º to prevent aspiration. If emesis occurs, then the infusion should be discontinued for 30 min and restarted at half the normal rate. Metoclopramide can be helpful as an antiemetic due to its prokinetic effects. Current recommendations are that the PEG is administered until the effluent is clear. The technique is not used routinely but may be considered where poisoning includes sustained release or enteric coated tablets. 9 It may also be used for drugs for which charcoal is known to be ineffective, for example, alcohols, boric acid, cyanide, iron, lithium, hydrocarbons, acids, and alkalis. It has been used with some success in the treatment of body packers, heavy metal, and battery ingestion. WBI is contraindicated in patients with an unprotected airway, haemodynamic instability, bowel obstruction, bowel perforation, or an ileus. Increased elimination Alkaline diuresis enhances the elimination of weak acids such as salicylates and some herbicides. Sodium bicarbonate is administered and the ph of the urine measured to keep the urinary ph Weak acids become charged in alkaline urine resulting in a concentration gradient drawing more toxin into the renal tubular system. Hypokalaemia can result from this technique and should be corrected aggressively. Alkaline diuresis should be used with caution in patients with renal impairment or cardiac disease. Treatment for specific poisons Acetaminophen Acetaminophen is responsible for hospital admissions a year and results in 345 deaths per annum. It is often one component of a mixed overdose. Acetaminophen produces the toxic metabolite N-acetyl-p-benzoqinone imine (NAPQI) which is neutralized by glutathione (Fig. 1). Depletion of glutathione results in NAPQI toxicity to hepatocytes. Patients particularly at risk are chronic alcoholics, those taking antiepileptic drugs, for example, carbamazepine and phenytoin (i.e. enzyme inducers) and patients receiving anti-tuberculous treatment, since they produce more NAPQI. Other patients at risk include those who have reduced glutathione stores due to such conditions as HIV, malnutrition, or terminal malignancy. A recent Cochrane review concluded that AC was more effective than gastric lavage or ipecac in reducing acetaminophen absorption. N-acetylcysteine (NAC) should be given, but the optimum dosing regimen remains uncertain. NAC may reduce the mortality of patients with fulminant liver failure. The superiority of NAC over methionine is unproven and 5% of patients receiving it will develop anaphylactoid reactions. Current advice from Toxbase is that high-risk patients should receive NAC at lower plasma acetaminophen concentrations (Fig. 2). Patients who develop fulminant liver failure may be offered life-saving liver transplantation, but the selection criteria are in need of refinement based on long-term outcome data. 11 Haemodialysis Haemodialysis is helpful in ethylene glycol, methanol, lithium, theophylline, and salicylate poisoning. The usefulness of this technique depends on the pharmacological properties of the ingested drug. The drug or poison should have a low volume of distribution (,1 litre kg 21 ), a low molecular weight (,500 Da), low protein binding, and low water solubility. 10 Fig 1 Acetaminophen metabolism. 8 Continuing Education in Anaesthesia, Critical Care & Pain j Volume 10 Number

4 Fig 2 Acetaminophen nomogram (permission from Prof. P.A. Routledge, Therapeutics and Toxicology Centre, Cardiff University). Salicylates Patients with salicylate poisoning may present with tinnitus, deafness, hyperventilation, epigastric pain, vomiting, hyperthermia, sweating, dehydration, respiratory alkalosis, metabolic acidosis, and electrolyte disturbances. Agitation and confusion may indicate the development of cerebral oedema which can be fatal. Treatment includes rehydration, treatment of acid base disturbance, and close monitoring of plasma levels. AC should be administered as soon as possible even in delayed presentations. The use of multidose AC is debatable, but should be considered if the plasma salicylate level continues to increase or if a slow release preparation has been taken. Alkalinization of the urine may increase the elimination of salicylate and should be considered in patients with signs of toxicity or in patients with plasma levels more than 300 mg litre 21. In patients with levels more than 700 mg litre 21, haemodialysis should be considered. Benzodiazepines Deaths associated with benzodiazepine overdose are due to mixed overdoses, especially alcohol and other drugs. Clinical manifestations are associated with drowsiness, respiratory depression, Table 2 Common antidotes Indicated in poisoning with Benzodiazepines Ethylene glycol, methanol Organophosphates Warfarin Cyanide Digoxin b-blockers Methaemoglobinaemia Acetaminophen Opiate Antidote Flumazenil Fomepizole and ethanol (10% for i.v. use) Atropine Factor II, VII, IX, X concentrate Dicobalt edetate, hydroxycobalamin Digibind Glucagon Methylene blue N-acetylcysteine Naloxone dysarthria, and ataxia. Coma is not common but is most often seen in the elderly or patients who have ingested alcohol or other drugs. Treatment is supportive. The use of flumazenil is controversial as it has many side-effects and is rarely indicated. Adverse effects include ventricular tachycardia, raising intracranial pressure, withdrawal in chronic abusers, and seizures if used in the presence of tricyclic antidepressants. It can be used to reverse benzodiazepine coma so as to avoid intubation, but this should be limited to situations of benzodiazepine overdose where no other drugs have been taken (Table 2). Continuing Education in Anaesthesia, Critical Care & Pain j Volume 10 Number

5 Opiates Increasing doses of opioids progressively produce euphoria, pinpoint pupils, sedation, respiratory depression, and apnoea. Complications include hypotension, convulsions, non-cardiogenic pulmonary oedema, and compartment syndrome from prolonged immobility. Where this is suspected, serum CK and urinary myoglobin should be measured to look for evidence of rhabdomyolysis. Naloxone should be given in 100 mg boluses i.v. to a maximum of 2 mg with the aim of reversing the opiate effect and reversing respiratory depression. This antidote can precipitate an acute agitated withdrawal state and when giving it staff should be mindful of their own safety. Naloxone can be administered i.v., i.m., s.c., or via the tracheal route. It has a short half-life (20 min if given i.v.) and therefore may be needed as an infusion since respiratory depression may reoccur. It can rarely cause ventricular dysrhythmias and hypertension and drowsiness at very high doses. Tricyclic antidepressants Tricyclic antidepressants cause 250 fatalities each year in the. The predominant cause of death is cardiac depression by sodium channel blockade with resultant decrease in cardiac output. Overdose presents with a sinus tachycardia, mydriasis, coma, hyperreflexia, convulsions, ECG changes, and hypotension. A QRS interval of.120 ms indicates cardiac toxicity and is predictive of ventricular arrhythmias and seizures. Treatment includes prevention of absorption using AC. Sodium bicarbonate is given as a loading dose (8.4% 1 2 ml kg 21 ) followed by an infusion or intermittent bolus. Sodium bicarbonate should be administered even in the absence of a significant metabolic acidosis as it helps to stabilize the Na channels in the myocardium and prevent cardiotoxicity. Convulsions can be treated with benzodiazepines initially, but anaesthesia with propofol may be required. Phenytoin is the anti-arrhythmic of choice and glucagon can be helpful if there is evidence of myocardial depression. Selective serotonin reuptake inhibitors These drugs include citalopram, fluoxetine, flovoxamine, paroxetine, and sertraline. Nausea, vomiting, agitation, tremor, nystagmus, drowsiness, dysrhythmias, and mild hypertension are the most common features of overdose. Convulsions have been reported up to 10 h post-ingestion. If administered with other drugs like cocaine, tricyclics MAOIs, or MDMA which release serotonin or affect its reuptake, this may result in serotonin syndrome. Serotonin syndrome consists of a triad of altered mental status, neuromuscular hyperactivity, and autonomic instability, similar in presentation to neuroleptic malignant syndrome hyperpyrexia, acidosis, arrythmias, and rhabdomyolysis are seen. Treatment is supportive but should include AC up to 1 h post-ingestion. Convulsions should be treated with benzodiazepines and phenytoin. Cryoheptadine and chlorpromazine are 5HT-2A antagonists and have successfully been used to treat serotonin syndrome, but there are no controlled trials to support the use of either agent. If rhabdomyolysis is suspected, urinary alkalinization and volume replacement may be helpful to reduce renal failure. Fluid resuscitation including 225 mmol of 8.4% sodium bicarbonate over 2 h is administered to increase urine ph to.7. If renal failure occurs, haemodialysis or haemofiltration is required. Methanol and ethylene glycol Methanol and ethylene glycol poisoning results in a severe high anion gap metabolic acidosis. Both are metabolized via the enzyme alcohol dehydrogenase resulting in formation of acids (formic, glycolic, and oxalic, respectively) which accumulate in the body and are responsible for neurological damage and death. Overdose with these agents can be treated with oral or nasogastric ethanol because of its greater affinity for alcohol dehydrogenase. However, maintaining plasma alcohol levels in the correct range is difficult and time-consuming, particularly if the patient is undergoing dialysis. Fomepizole blocks the metabolism of methanol and ethanol and can be injected 12 hourly. It is expensive and not widely available. Folate deficiency in primates is predictive of poor outcome in methanol toxicity and it is suggested that folate be given in a dose of 1 mg kg 21 day 21 for 48 h. 12 Summary Acute poisoning is relatively common and is the cause of significant morbidity and mortality. NPIS and Toxbase provide a 24 h information service for all aspects of poisoning. Treatment of poisoning remains largely supportive. Few drugs have antidotes and therefore treatment is aimed at reducing further absorption of the drug, increasing its elimination, and treating the side-effects. Gastric decontamination with AC is time-dependent, but can significantly reduce drug absorption. Forced emesis and gastric lavage are no longer recommended. References 1. Greene SL, Dargan PI, Jones AL. Acute poisoning: understanding 90% of case in a nutshell. Postgrad Med J 2005; 81: Jones A, Dargan P, Greene S et al. Guy s and St Thomas Poisons Unit Annual Report Good AM, Bateman DN. National Poisons Information Service Annual Report, 2005/ Heard K. The changing indications of the gastrointestinal decontamination in poisonings. Clin Lab Med 2006; 26: Krenzelok EP, McGuigan M, Lheur P. Position Paper: Ipecac Syrup American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Clin Toxicol 2004; 42: Vale JA. Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35: Chyka PA, Seger D. Position statement: single dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin 1997; 35: Continuing Education in Anaesthesia, Critical Care & Pain j Volume 10 Number

6 8. Green R, Grierson R, Sitar DS, Tenenbein M. How long after drug ingestion is activated charcoal still effective? J Toxicol Clin Toxicol 2001; 39: Lapatto-Reiniluoto O, Kivisto KT, Neuvonen PJ. Activated charcoal alone and followed by whole bowel irrigation in preventing the absorption of sustained release drugs. Clin Pharmacol Ther 2001; 70: Jones LO. Poisoning. Anaesth Intensive Care Med 2006; 7: Brok J, Buckley N, Gluud C. Interventions for Paracetamol (Acetaminophen) Overdose (Review), The Cochrane Library, Issue 3, Wiley, 2008; Brent J, Mcmartin K, Philips S, Aaron C, Kulig K. Fomepizole in the treatment of methanol poisoning. N Engl J Med 2001; 344: 24 2 Please see multiple choice questions 5 7 Continuing Education in Anaesthesia, Critical Care & Pain j Volume 10 Number

Salicylates commonly cause tinnitus, deafness, nausea and vomiting (salicylism). Hyperventilation results from stimulation of respiratory centre.

Salicylates commonly cause tinnitus, deafness, nausea and vomiting (salicylism). Hyperventilation results from stimulation of respiratory centre. Aspirin poisoning CLINICAL FEATURES Salicylates commonly cause tinnitus, deafness, nausea and vomiting (salicylism). Hyperventilation results from stimulation of respiratory centre. Severe poisoning causes

More information

Clinical Pathway: Management Of The Life-Threatening Overdose

Clinical Pathway: Management Of The Life-Threatening Overdose Clinical Pathway: Management Of The Life-Threatening Overdose Intravenous access Oxygen Pulse oximetry n-invasive blood pressure monitoring Accu-Check ECG monitoring and ECG Chest x-ray Respiratory depression?

More information

Chapter 13. Learning Objectives. Learning Objectives 9/11/2012. Poisonings, Overdoses, and Intoxications

Chapter 13. Learning Objectives. Learning Objectives 9/11/2012. Poisonings, Overdoses, and Intoxications Chapter 13 Poisonings, Overdoses, and Intoxications Learning Objectives Discuss use of activated charcoal in treatment of poisonings List treatment options for acetaminophen overdose List clinical manifestations

More information

INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to: Care of the Poisoned Patient WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017 RN.ORG, S.A.,

More information

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Charcodote 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Activated charcoal 200mg/ml 3. PHARMACEUTICAL FORM Oral suspension 4. CLINICAL

More information

POISON ANTIDOTE DOSE* COMMENTS

POISON ANTIDOTE DOSE* COMMENTS Antidotes Acetaminophen N-acetylcysteine 140 mg/kg initial oral dose, followed Most effective within 16 24 hr; may by 70 mg/kg every 4 hr 17 doses be useful after chronic intoxication or intravenously

More information

Poisoning in children

Poisoning in children Lisa Penny MBChB MRCS Ed (A&E) FRCA Tony Moriarty MBBS FRCA Suspected poisoning in children results in about 40 000 annual Emergency Department attendances in England and Wales, with approximately half

More information

A lthough the overall severity of poisoning in

A lthough the overall severity of poisoning in 204 REVIEW Acute poisoning: understanding 90% of cases in a nutshell S L Greene, P I Dargan, A L Jones... The acutely poisoned patient remains a common problem facing doctors working in acute medicine

More information

PDP 406 CLINICAL TOXICOLOGY

PDP 406 CLINICAL TOXICOLOGY PDP 406 CLINICAL TOXICOLOGY Pharm.D Fourth Year Mr.D.Raju.M.Pharm., Lecturer INTRODUCTION It is the process of freeing of a person or object of some contaminating substance from intestine which further

More information

Salicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes

Salicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes Salicylate (Aspirin) Ingestion California Poison Control 1-800-876-4766 Background 1. The prevalence of aspirin-containing analgesic products makes these agents, found in virtually every household, common

More information

Welcome Applicants! FRIDAY, OCTOBER 24

Welcome Applicants! FRIDAY, OCTOBER 24 Welcome Applicants! FRIDAY, OCTOBER 24 Friday Prep A 3-year-old girl is brought to your office for re-evaluation of a fever that began 6 days ago. Her mother tells you that her daughter s temperature has

More information

Neither activated charcoal nor whole bowel irrigation (WBI) is indicated in the routine management of acute or chronic lithium toxicity.

Neither activated charcoal nor whole bowel irrigation (WBI) is indicated in the routine management of acute or chronic lithium toxicity. CRACKCast E160 Lithium Key concepts; The clinical pattern of acute and chronic toxicity is different. Gastrointestinal symptoms occur early and neurological toxicity manifest late in acute toxicity. Neurological

More information

PARACOD Tablets (Paracetamol + Codeine phosphate)

PARACOD Tablets (Paracetamol + Codeine phosphate) Published on: 22 Sep 2014 PARACOD Tablets (Paracetamol + Codeine phosphate) Composition PARACOD Tablets Each effervescent tablet contains: Paracetamol IP...650 mg Codeine Phosphate IP... 30 mg Dosage Form/s

More information

Paracetamol Naloxone Opkast Kul - HVAD VED VI?

Paracetamol Naloxone Opkast Kul - HVAD VED VI? Paracetamol Naloxone Opkast Kul - HVAD VED VI? Læge Søren Steemann Rudolph Rigshospitalet København nothing to disclaim Paracetamol NAC treatment is not indicated when s-paracetamol is zero Naloxone After

More information

Poisoning: from paracetamol to legal highs.

Poisoning: from paracetamol to legal highs. Poisoning: from paracetamol to legal highs. or Something old, something new, something borrowed, something blue. Nick Bateman University of Edinburgh Question 1 Which of the following agents was associated

More information

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY TRAPADOL INJECTION FOR I.V./I.M. USE ONLY Composition : Each 2ml. contains : Tramadol Hydrochloride I.P. Water for injection I.P. 100mg. q.s. CLINICAL PHARMACOLOGY : Pharmacodynamics Tramadol is a centrally

More information

Poison (Toxicant): any substance or agent capable of producing a deleterious response in a biological system or living organism.

Poison (Toxicant): any substance or agent capable of producing a deleterious response in a biological system or living organism. Poison (Toxicant): any substance or agent capable of producing a deleterious response in a biological system or living organism. Poisoning= overdose toxicity intoxication= toxicity due to foreign substance

More information

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms:

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms: Opioid Overdose Best Practices Guideline Table of Contents A. General description B. Typical signs and symptoms C. Expected course D. Making the diagnosis E. Recommended treatment F. Criteria for hospital

More information

Dr Noluthando Nematswerani Department of Pharmacology

Dr Noluthando Nematswerani Department of Pharmacology Dr Noluthando Nematswerani Department of Pharmacology All substances are poisons; there is none which is not a poison. The right dose differentiates a poison and a remedy. Paracelsus (1493-1541) Intentional

More information

Medication Overdoses. By LT Jimson & Shawn Hunsberger

Medication Overdoses. By LT Jimson & Shawn Hunsberger Medication Overdoses By LT Jimson & Shawn Hunsberger Pharmacology Review First, some terms: Affinity - the tendency of a drug to combine with its receptor Efficacy the drugs ability to initiate biological

More information

Pediatric Toxicologic Emergencies

Pediatric Toxicologic Emergencies Pediatric Toxicologic Emergencies Martin Belson, MD Department of Pediatrics Georgia Poison Center Emory University I. Epidemiology A. Over 2 million poison exposures reported in 2003 B. 53% of these exposures

More information

99 Problems but hyperglycemia ain t one SHEEREENE HUSSAIN MD, MA RAPID CITY REGIONAL HOSPITAL HOSPITALIST DEPARTMENT SEPT 12, 2018

99 Problems but hyperglycemia ain t one SHEEREENE HUSSAIN MD, MA RAPID CITY REGIONAL HOSPITAL HOSPITALIST DEPARTMENT SEPT 12, 2018 99 Problems but hyperglycemia ain t one SHEEREENE HUSSAIN MD, MA RAPID CITY REGIONAL HOSPITAL HOSPITALIST DEPARTMENT SEPT 12, 2018 ER Admit 17 yo F reported intentional overdose handful of her mother s

More information

Dancing with Death: MDMA, PMMA and other 4 letter words

Dancing with Death: MDMA, PMMA and other 4 letter words Dancing with Death: MDMA, PMMA and other 4 letter words Mark Yarema, MD FRCPC Poison and Drug Information Service Alberta Health Services AARC Community Intervention Series March 15, 2016 Objectives At

More information

NEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face.

NEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face. 1. PRODUCT NAME ACUPAN 30 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains nefopam hydrochloride 30 mg. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM

More information

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal SVT 1 st Dose 6 mg rapid IV 2 nd & 3 rd Doses 12 mg rapid IV push Follow each dose with rapid bolus of 20 ml NS May cause transient heart block or asystole. Side effects include chest

More information

Basics and Decontamination in Clinical Toxicology

Basics and Decontamination in Clinical Toxicology ! Klinikum rechts der Isar Technische Universität München Basics and Decontamination in Clinical Toxicology! Toxi-Latin Porto Alegre 2014 Florian Eyer Toxicological Department 2nd Medizinische Klinik Klinikum

More information

Updates on clinical management of recreational drug use: what s new and how do we treat it?

Updates on clinical management of recreational drug use: what s new and how do we treat it? Updates on clinical management of recreational drug use: what s new and how do we treat it? Matt Noble, MD MPH Oregon Poison Center OHSU Department of Emergency Medicine Objectives Review the basic conceptual

More information

PRODUCT INFORMATION. (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate

PRODUCT INFORMATION. (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate NORGESIC Orphenadrine citrate and paracetamol PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Chemical name: CAS number: 4682-36-4 Chemical structure: Orphenadrine citrate (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine

More information

PRODUCT INFORMATION RESONIUM A. Na m

PRODUCT INFORMATION RESONIUM A. Na m PRODUCT INFORMATION RESONIUM A NAME OF THE MEDICINE Non-proprietary Name Sodium polystyrene sulfonate Chemical Structure CH - 2 CH SO 3 Na + n CAS Number 28210-41-5 [9003-59-2] CH 2 CH SO - 3 m DESCRIPTION

More information

CLINICAL TOXICOLOGY. Gábor Zacher Dept. Emergency Medicine Central Military Hospital

CLINICAL TOXICOLOGY. Gábor Zacher Dept. Emergency Medicine Central Military Hospital CLINICAL TOXICOLOGY Gábor Zacher Dept. Emergency Medicine Central Military Hospital LEARNING OBJECTIVES To understand the general principles of clinical toxicology To know general factors that influence

More information

A review of the management of oral drug overdose in the Accident and Emergency Department of the Royal Brisbane Hospital

A review of the management of oral drug overdose in the Accident and Emergency Department of the Royal Brisbane Hospital Archives of Emergency Medicine, 1991, 8, 8-16 A review of the management of oral drug overdose in the Accident and Emergency Department of the Royal Brisbane Hospital D. W. HODGKINSON, L. B. JELLETT &

More information

Emergency Toxicology. Piyachat Sasipattarapong, MD, FTCEP Emergency Medicine Khon Kaen Hospital

Emergency Toxicology. Piyachat Sasipattarapong, MD, FTCEP Emergency Medicine Khon Kaen Hospital Emergency Toxicology Piyachat Sasipattarapong, MD, FTCEP Emergency Medicine Khon Kaen Hospital Dose Therapeutic index Determination of Toxicity Route of exposure GI, Inhalation, Cutaneous Host Extreme

More information

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS Guideline Title Summary of Product Characteristics for Benzodiazepines as Anxiolytics or Hypnotics Legislative basis Directive

More information

M0BCore Safety Profile

M0BCore Safety Profile M0BCore Safety Profile Active substance: Aciclovir Pharmaceutical form(s)/strength: Tablets 200, 400 or 800 mg Dispersible tablets 200, 400 or 800 mg Oral suspensions 200 mg or 400 mg per 5 ml. Freeze

More information

Active ingredients: Metoclopramide Hydrochloride mg Equivalent to metoclopramide hydrochloride anhydrous mg

Active ingredients: Metoclopramide Hydrochloride mg Equivalent to metoclopramide hydrochloride anhydrous mg Name Primperan 10 mg / 2 ml Metoclopramide hydrochloride anhydrous Solution for I.M. or I.V. injection (Ampoules) Composition Each 2 ml ampoule contains: Active ingredients: Metoclopramide Hydrochloride.

More information

Advice for healthcare professionals in any setting

Advice for healthcare professionals in any setting Advice for healthcare professionals in any setting General principles Always treat people with care and respect Ensure privacy for service user Take full account of the likely distress associated with

More information

European PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam

European PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam European PSUR Work Sharing Project CORE SAFETY PROFILE Lendormin, 0.25mg, tablets Brotizolam 4.2 Posology and method of administration Unless otherwise prescribed by the physician, the following dosages

More information

SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less. For pack sizes of more than 24 tablets

SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less. For pack sizes of more than 24 tablets SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less S1 For pack sizes of more than 24 tablets PROPRIETARY NAME: AND DOSAGE FORM PANADO MELTABS (Tablets) COMPOSITION: Each tablet contains 500 mg

More information

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold

More information

Adult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES

Adult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES Adult Drug Reference Dopamine Drip Chart Pediatric Drug Reference Pediatric Drug Dosage Charts DRUG REFERENCES ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal

More information

Toxicologic Emergencies. Objectives. Priorities. CAPA 2015 Annual Conference

Toxicologic Emergencies. Objectives. Priorities. CAPA 2015 Annual Conference Toxicologic Emergencies Jed Grant, MPAS, PA-C Staff PA, Emergency Department, Mercy San Juan Medical Center, Sacramento, CA Assistant Professor, University of the Pacific PA Program, Sacramento, CA Vice

More information

Episode 90 Low and Slow Poisoning

Episode 90 Low and Slow Poisoning Hyperkalemia Myxedema coma Spinal cord injury Hypothermia Episode 90 Low and Slow Poisoning With Drs. Margaret Thompson & Emily Austin Prepared by Dr. Keerat Grewal, edited by Dr. Anton Helman, Jan 2017

More information

Core Safety Profile. Pharmaceutical form(s)/strength: Tablets 5 mg and 10 mg BE/H/PSUR/0002/002 Date of FAR:

Core Safety Profile. Pharmaceutical form(s)/strength: Tablets 5 mg and 10 mg BE/H/PSUR/0002/002 Date of FAR: Core Safety Profile Active substance: Clotiazepam Pharmaceutical form(s)/strength: Tablets 5 mg and 10 mg P-RMS: BE/H/PSUR/0002/002 Date of FAR: 16.06.2011 4.3 Contraindications is contraindicated

More information

By Michael M.H. Yang. Toxic Ingestion. Background

By Michael M.H. Yang. Toxic Ingestion. Background Toxic Ingestion Background Accidental and intentional exposures to toxic substances occur in children of all ages. Children younger than age 6 years are primarily involved in accidental exposures, with

More information

2/1/2013. Anti dos and don ts: Pearls and pitfalls in the use of antidotes. The first rule of surfing... The ABC s of the poisoned patient

2/1/2013. Anti dos and don ts: Pearls and pitfalls in the use of antidotes. The first rule of surfing... The ABC s of the poisoned patient According to the American Academy of Poison Control Centers, what is the most common intervention performed in the management of acutely poisoned patients? Anti dos and don ts: Pearls and pitfalls in the

More information

How effective is chelation? contrasts in iron and digoxin poisoning. Nick Bateman Edinburgh

How effective is chelation? contrasts in iron and digoxin poisoning. Nick Bateman Edinburgh How effective is chelation? contrasts in iron and digoxin poisoning Nick Bateman Edinburgh Chelation Chemical chelating agents chemical that bind metal ions and other toxic groups e.g. desferrioxamine

More information

Contra Costa County Emergency Medical Services Drug Reference. Indication Dosing Cautions Comments

Contra Costa County Emergency Medical Services Drug Reference. Indication Dosing Cautions Comments Drug Adenosine Albuterol Indication Dosing Cautions Comments Narrow complex tachycardia Bronchospasm Crush injury - hyperkalemia Initial 6mg rapid IV Repeat 12mg rapid IV Follow each dose with 20ml NS

More information

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.

More information

Antidotes in acute intoxications P. De Paepe and W. Buylaert - 25/08/2007

Antidotes in acute intoxications P. De Paepe and W. Buylaert - 25/08/2007 Antidotes in acute intoxications Antidotes: warnings Antidotes are only one aspect of treatment In case of uncommon antidotes: seek expert advice These slides only discuss the general principles, not the

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2. QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Acetylcysteine 200 mg/ml Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Acetylcysteine 200 mg per ml. Each 10ml ampoule contains

More information

Anaesthesia. Poisoning. Update in. Emergency management of poisoning. S Heikal, A Appelboam, R Appelboam Correspondence

Anaesthesia. Poisoning. Update in. Emergency management of poisoning. S Heikal, A Appelboam, R Appelboam Correspondence Update in Anaesthesia Emergency management of poisoning S Heikal, A Appelboam, R Appelboam Correspondence Email: sarah.heikal@gmail.com INTRODUCTION Drug overdose and poisoning is a global public health

More information

1995 Called - They Want Your Boring Lectures Back Bringing Tech into the Classroom

1995 Called - They Want Your Boring Lectures Back Bringing Tech into the Classroom 1995 Called - They Want Your Boring Lectures Back Bringing Tech into the Classroom Corey Heitz, MD Department of Emergency Medicine Who is apprehensive about using newer teaching technologies? Why? Sage

More information

Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules.

Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules. Nausicalm Cyclizine lactate 50 mg/ml solution for injection Presentation Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules. Uses Actions Cyclizine is a piperazine

More information

Summary of risk management plan for Dzuveo (Sufentanil (as citrate))

Summary of risk management plan for Dzuveo (Sufentanil (as citrate)) Part VI: Summary of the risk management plan Summary of risk management plan for Dzuveo (Sufentanil (as citrate)) This is a summary of the risk management plan (RMP) for Dzuveo. The RMP details important

More information

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR: M0BCore Safety Profile Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg P-RMS: FR/H/PSUR/0066/001 Date of FAR: 26.11.2013 4.3 Contraindications Bromazepam must not be administered

More information

Overdose & Poisoning

Overdose & Poisoning Overdose & Poisoning J.R. Sheller, M.D., M.A. Professor of Medicine Medical Director MICU NP Service With special thanks and gratitude to Dr. Art Wheeler Overview ~6% of MICU admissions are overdoses

More information

POISONING AND DRUG OVERDOSAGE

POISONING AND DRUG OVERDOSAGE POISONING AND DRUG OVERDOSAGE Department of Internal Medicine WAN Weiguo General Info All chemicals have potential to be poisons if given a large enough dose Poisoning occurs when exposure to a substance

More information

PRODUCT INFORMATION ANAGRAINE. Each ANAGRAINE tablet contains 5 mg metoclopramide and 500 mg paracetamol.

PRODUCT INFORMATION ANAGRAINE. Each ANAGRAINE tablet contains 5 mg metoclopramide and 500 mg paracetamol. PRODUCT INFORMATION ANAGRAINE COMPOSITION Each ANAGRAINE tablet contains 5 mg metoclopramide and 500 mg paracetamol. ACTIONS Metoclopramide stimulates gastrointestinal tract motility and accelerates gastric

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our

More information

Restlessness, muscle twitches, and diarrhea.

Restlessness, muscle twitches, and diarrhea. http://www.medicine-on-line.com Restlessness, twitches & diarrhea: 1/7 Case 062: Restlessness, muscle twitches, and diarrhea. Authors: * Jason Ko MB BS, MRCP # David C Chung MD, FRCPC Affiliations: *Tuen

More information

Toxicology. Steven E. Pass, Pharm.D., FCCP, FCCM, FASHP, BCPS. Texas Tech University Health Sciences Center School of Pharmacy Dallas, Texas

Toxicology. Steven E. Pass, Pharm.D., FCCP, FCCM, FASHP, BCPS. Texas Tech University Health Sciences Center School of Pharmacy Dallas, Texas Steven E. Pass, Pharm.D., FCCP, FCCM, FASHP, BCPS Texas Tech University Health Sciences Center School of Pharmacy Dallas, Texas Toxicology Steven E. Pass, Pharm.D., FCCP, FCCM, FASHP, BCPS Texas Tech

More information

Drug Interactions Year 2 Clinical Pharmacology

Drug Interactions Year 2 Clinical Pharmacology 1 Drug Interactions Year 2 Clinical Pharmacology Prof Mark McKeage Department of Pharmacology & Clinical Pharmacology 2 Objectives Explain the potential for interacting drugs to cause beneficial and harmful

More information

Chapter 143 Acetaminophen

Chapter 143 Acetaminophen Chapter 143 Acetaminophen Episode overview 1) Describe the metabolism of Acetaminophen 2) Describe the 4 stages of Acetaminophen toxicity 3) List 4 mechanism of action of N-acetylcysteine 4) When do you

More information

Toxicology General Approach to the Poisoned Patient James Sinex, MD., FACEP

Toxicology General Approach to the Poisoned Patient James Sinex, MD., FACEP General Approach to the Poisoned Patient James Sinex, MD., FACEP Definition of Terms Poisoning can be defined as exposure to a chemical or other agent that adversely affects functioning of an organism.

More information

1/29/2014. Objectives. The unstable overdose patient. Unstable overdose case #1. Outline

1/29/2014. Objectives. The unstable overdose patient. Unstable overdose case #1. Outline Objectives The unstable overdose patient Craig Smollin MD Associate Medical Director California Poison Control Center, SF Division Discuss clinical scenarios unique to the acutely poisoned patient and

More information

Severely Poisoned Patients Requiring Critical Care

Severely Poisoned Patients Requiring Critical Care Severely Poisoned Patients Requiring Critical Care Dr Anna Lee, CICM, FANZCA, FHKAM Department of Anaesthesia and Intensive Care Prince of Wales Hospital, Hong Kong Disclaimer I am not a toxicologist!

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET 1 PRODUCT NAME Acetylcysteine 200 mg/ml Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Acetylcysteine 200 mg per ml (as N-acetylcysteine) Each 10 ml ampoule contains 2 g N-acetylcysteine Excipients

More information

Chapter 19 Toxicology Introduction Definitions Consider Poisoning In Patients With: Identifying the Patient and the Poison

Chapter 19 Toxicology Introduction Definitions Consider Poisoning In Patients With: Identifying the Patient and the Poison 1 2 3 4 5 Chapter 19 Toxicology Introduction Each day, we come into contact with things that are potentially poisonous. Acute poisoning affects 5 million people each year. Chronic is much more common.

More information

EM Cases Course 2017 Toxicology Module

EM Cases Course 2017 Toxicology Module EM Cases Course 2017 Toxicology Module quick IV access and diazepam is administered. The seizure stops. The first set of vitals show: HR 30bpm, BP 70/40. His ECG is shown below. Margaret Thompson & JP

More information

Local anaesthetics. Dr JM Dippenaar

Local anaesthetics. Dr JM Dippenaar Local anaesthetics Dr JM Dippenaar Chemical structure Lipophilic phenol ring + Amide/Ester bridge + Hydrophilic chain Local anesthetic drugs Amides Esters Lignocaine Cocaine Bupivacaine PABA esters Ropivacaine

More information

Migraleve, Migraleve Pink and Migraleve Yellow Product Information

Migraleve, Migraleve Pink and Migraleve Yellow Product Information Migraleve, Migraleve Pink and Migraleve Yellow Product Information Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard Adverse events should also

More information

1 Chapter 19 Toxicology 2 Introduction Each day, we come into contact with things that are potentially poisonous. Acute poisoning affects 5 million

1 Chapter 19 Toxicology 2 Introduction Each day, we come into contact with things that are potentially poisonous. Acute poisoning affects 5 million 1 Chapter 19 Toxicology 2 Introduction Each day, we come into contact with things that are potentially poisonous. Acute poisoning affects 5 million people each year. Chronic is much more common. Caused

More information

ACETYLCYSTEINE INJECTION

ACETYLCYSTEINE INJECTION ACETYLCYSTEINE INJECTION 1. Name of the medicinal product Acetylcysteine 200 mg/ml Injection 2. Qualitative and quantitative composition Acetylcysteine 200mg per ml (as N-acetylcysteine) Each 10ml ampoule

More information

Drug toxicity. Over the counter drugs

Drug toxicity. Over the counter drugs Drug toxicity Over the counter drugs Caffeine toxicity Caffeine (1,3,7-trimethylxanthine) is the most widely consumed stimulant drug in the world. It is present in a variety of forms: medications, coffee,

More information

Paracetamol Poisoning in Children

Paracetamol Poisoning in Children Introduction Paracetamol Poisoning in Children Rojo Joy Junior Resident-Pediatrics, JIPMER, Puducherry Rojo Villa, 33/5600, Chevayur P.O, Calicut, Kerala Paracetamol is one of the most commonly used drug

More information

Uses Location(s) Par Levels a Location(s) Par Levels. Min: 18 Max: 36. Min: 22 Max: 33. Talyst (Refrig) Talyst (Refrig) Min: 2 b Talyst (Refrig)

Uses Location(s) Par Levels a Location(s) Par Levels. Min: 18 Max: 36. Min: 22 Max: 33. Talyst (Refrig) Talyst (Refrig) Min: 2 b Talyst (Refrig) U N C M E D I C A L C E N T E R G U I D E Antidotes Used in Poisonings and Ingestions The purpose of this guide is to describe the locations and quantities of antidotes to be maintained at UNC Medical

More information

Chapter 149 Aspirin and Nonsteroidal Agents

Chapter 149 Aspirin and Nonsteroidal Agents Chapter 149 Aspirin and Nonsteroidal Agents Episode overview: Core questions: 1. What is the pathophysiology of ASA toxicity? 2. What is the toxic dose of ASA? 3. How is aspirin eliminated from the body?

More information

CLICK ON A TOPIC BELOW

CLICK ON A TOPIC BELOW CLICK ON A TOPIC BELOW AMLS Patient Assessment Pathway Contiguous Leads Common Laboratory Values Selected Common Toxidromes AMLS Patient Assessment Pathway INITIAL OBSERVATIONS Scene/Situation Safety threats

More information

Update in Poison Management. Update in Poison Management. Antidote Use. Fomepizole. Pediatric Ingestions 1. No financial disclosures

Update in Poison Management. Update in Poison Management. Antidote Use. Fomepizole. Pediatric Ingestions 1. No financial disclosures Update in Poison Management No financial disclosures Robert J. Hoffman, MD,MS FACMT, FACEP, FAAEM, FAAP Department of Emergency Medicine Albert Einstein College of Medicine New York, New York Update in

More information

Substance Abuse and Poisonings. Chapter 17

Substance Abuse and Poisonings. Chapter 17 Substance Abuse and Poisonings Chapter 17 Identifying the Patient and the Poison Poison- any substance who s chemical reaction can damage body structures or impair body functions Poisons act by changing

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 80mg Suppositories 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each suppository contains 80mg Paracetamol For a full list of

More information

CRACKCast Episode Hydrocarbons (Ch th )

CRACKCast Episode Hydrocarbons (Ch th ) CRACKCast Episode Hydrocarbons (Ch. 152 9 th ) Episode Overview Key Concepts: Aspiration is the major toxic risk of hydrocarbon poisoning. Hydrocarbons may cause systemic toxicity, burns, seizures, cardiac

More information

SALICYLATES. Anthony F. Pizon, M.D. Associate Professor Division Medical Toxicology University of Pittsburgh School of Medicine

SALICYLATES. Anthony F. Pizon, M.D. Associate Professor Division Medical Toxicology University of Pittsburgh School of Medicine SALICYLATES Anthony F. Pizon, M.D. Associate Professor Division Medical Toxicology University of Pittsburgh School of Medicine Overview: Salicylates Found in Willow bark (Salix alba vulgaris) Widely used

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Prometazin Actavis 25 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 25 mg of promethazine

More information

Caring for the Poisoned Patient

Caring for the Poisoned Patient #34442 Caring for the Poisoned Patient COURSE #34442 5 CONTACT HOURS Release Date: 04/01/18 Expiration Date: 03/31/21 Caring for the Poisoned Patient HOW TO RECEIVE CREDIT Read the enclosed course. Complete

More information

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytic, Sedative and Hypnotic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytics: reduce anxiety Sedatives: decrease activity, calming

More information

OPTIMIZING YOUR DIAGNOSIS OF THE POISONED PATIENT Justine A. Lee, DVM, DACVECC Pet Poison Helpline, Minneapolis, MN

OPTIMIZING YOUR DIAGNOSIS OF THE POISONED PATIENT Justine A. Lee, DVM, DACVECC Pet Poison Helpline, Minneapolis, MN OPTIMIZING YOUR DIAGNOSIS OF THE POISONED PATIENT Justine A. Lee, DVM, DACVECC Pet Poison Helpline, Minneapolis, MN 55425 jlee@petpoisonhelpline.com INTRODUCTION Pet Poison Helpline, an international,

More information

PATIENT GROUP DIRECTION (PGD)

PATIENT GROUP DIRECTION (PGD) PATIENT GROUP DIRECTION (PGD) SUPPLY OF NALOXONE HYDROCHLORIDE INJECTION BY REGISTERED NURSES TO CLIENTS BEING RELEASED FROM HMP FORD Version Number: 01HMP Patient Group Direction originally drawn up by:

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT "Carbellon" Tablets. 2. Qualitative and Quantitative Composition Active Constituents: Activated Charcoal Ph.Eur. Magnesium Hydroxide Ph.Eur.

More information

Atropine therapy in acute anticholinesterase (Organophosphorus / carbamate) poisoning; adherence to current guidelines

Atropine therapy in acute anticholinesterase (Organophosphorus / carbamate) poisoning; adherence to current guidelines Atropine therapy in acute anticholinesterase (Organophosphorus / carbamate) poisoning; adherence to current guidelines 1,,3 1 3 Jayasinghe SS, Fernando A, Pathirana KD, K Kishanthi Gunasinghe 1 Department

More information

ROS: all remaining ROS negative

ROS: all remaining ROS negative Case # 1 CC: altered mental status HPI: 13 yo male presents with altered metal status. Child`s mother was called by the school nurse to pick her child up from school today due to child`s unusual behavior.

More information

Management of Poisoning

Management of Poisoning Objectives Management of Poisoning Dr Muhammad Elamin Consultant in Clinical Toxicology At the end of the session you should be able to: Manage acute paracetamol toxicity Describe the management of patients

More information

Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS)

Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS) Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS) Georgios Dadoudis Anesthesiologist ICU DIRECTOR INTERBALKAN MEDICAL CENTER Optimal performance requires:

More information

DR J HARTY / DR CM RITCHIE / DR M GIBBONS

DR J HARTY / DR CM RITCHIE / DR M GIBBONS CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Paracetamol Poisoning DR J HARTY / DR CM RITCHIE / DR M GIBBONS Medicine Acute Date Uploaded: 16 th September 2014 Review Date

More information

DBL NALOXONE HYDROCHLORIDE INJECTION USP

DBL NALOXONE HYDROCHLORIDE INJECTION USP Name of medicine Naloxone hydrochloride Data Sheet New Zealand DBL NALXNE HYDRCHLRIDE INJECTIN USP Presentation DBL Naloxone Hydrochloride Injection USP is a sterile, clear, colourless solution, free from

More information

Now available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet

Now available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet Now available SUBOXONE Once-daily dosing1 12 mg and 16 mg tablets A maintenance dose of SUBOXONE 12-16 mg once daily is clinically effective for most patients*1 Effective maintenance dosing with SUBOXONE

More information

PRODUCT INFORMATION LOFENOXAL

PRODUCT INFORMATION LOFENOXAL PRODUCT INFORMATION LOFENOXAL Diphenoxylate hydrochloride 2.5 mg and Atropine sulfate 25 microgram Name of the medicines Diphenoxylate Hydrochloride: C30H32N2O2, HCl M. W. = 489.1 CAS registry no.: 3810-80-8

More information

PRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets

PRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets PRODUCT INFORMATION SUDAFED Sinus 12 Hour Relief Tablets NAME OF THE MEDICINE Pseudoephedrine Hydrochloride CAS 2 Registry Number: 345-78-8 DESCRIPTION SUDAFED Sinus 12 Hour Relief prolonged-release tablets

More information

Anti-Depressant Medications

Anti-Depressant Medications Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change

More information

SANDOMIGRAN (pizotifen malate)

SANDOMIGRAN (pizotifen malate) SANDOMIGRAN (pizotifen malate) S N CH 3 Pizotifen. COOH CH OH CH 2 COOH MALATE DESCRIPTION Pizotifen is a cycloheptathiophene derivative structurally related to cyproheptadine and the tricyclic antidepressants.

More information